Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Haematologica - 1 Sept 2016

Blombery Piers, Thompson Ella R, Jones Kate, Arnau Gisela Mir, Lade Stephen, Markham John F, Li Jason, Deva Anand, Johnstone Ricky W, Khot Amit, Prince H Miles, Westerman David

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ascitic Fluid
Share to Breast Neoplasms
Share to Exome Sequencing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Janus Kinase 1

Share to Lymphoma, Large-Cell, Anaplastic

Share to Mutation

Share to STAT3 Transcription Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 27198716
DOI: 10.3324/haematol.2016.146118
PMCID: PMC5060038

Genes

JAK1
STAT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.PMID 27198716Read ↗

Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.Semantic proximity Read ↗

Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.Semantic proximity Read ↗

Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphomaSemantic proximity Read ↗

Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.Semantic proximity Read ↗

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).Semantic proximity Read ↗

Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.Semantic proximity Read ↗

Evaluation of Breast Implant-Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing.Semantic proximity Read ↗

Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation.Semantic proximity Read ↗

A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical DiscoveriesSemantic proximity Read ↗

BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations.Semantic proximity Read ↗

Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.Semantic proximity Read ↗

Proteogenomic Characterization of Triple-Negative Apocrine Carcinoma Reveals Molecular Features of Progression and Chemotherapy ResponseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.